Anil Kumar Sharma

Anil Kumar Sharma

Auto-generated profile, based on publicly available information

Anil Kumar Sharma

Amity University, Mohali, Punjab

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
ASAnil Kumar Sharma
Anil Kumar Sharma
AAAmit Arya
Amit Arya
PSPravat Kumar Sahoo
Pravat Kumar Sahoo
DMDipak Kanti Majumdar
Dipak Kanti Majumdar

17 May 2016 in Drug Delivery
Verified
Journal Article
Closed access
ASAnil K. Sharma
Anil K. Sharma
PSPravat K. Sahoo
Pravat K. Sahoo
DMDipak K. Majumdar
Dipak K. Majumdar
NSNavneet Sharma
Navneet Sharma
RSRakesh Sharma
Rakesh Sharma
AKAmit Kumar
Amit Kumar
Context: The unique physiological limitations of the eye have been assigned as reason of low bioavailability by conventional drug delivery systems. There is need of such drug carriers, which ensure improved bioavailability as well as patient compliance upon instillation into the eye. Objective: The present investigation deals with development of solid lipid nanoparticles (SLNs) containing celecoxib (CXB) for treatment of ophthalmic inflammations. Materials and methods: The SLNs were formulated by melt-emulsion sonication and low temperature-solidification process and evaluated for particle size, surface morphology, physicochemical properties, percentage drug incorporation efficiency, in vitro drug release, in vitro trans-corneal permeation, in vivo efficacy in ocular inflammation, stability study and gamma scintigraphy study to assess the residence of solid lipid nanoparticles over ocular surfaces. Results: The SLNs were spherical and the optimized formulation had particle size of 198.77 ± 7.5 nm, which is quite suitable for ocular applications. The maximum entrapment efficiency of 92.46 ± 0.07% was achieved for formulation SLN 20. The permeation across the cornea was also significantly better than aqueous suspension (8.21 ± 0.67 versus 4.61 ± 0.71) at p < 0.05. Discussion and conclusion: The SLN formulations demonstrated improved performance of entrapped CXB while mitigating the key parameters of ocular inflammation in rabbits. The particulate formulations have exhibited prolonged retention over ocular surfaces as evident from results of gamma scintigraphy using 99mTc labeled SLNs.

11 June 2016 in Nanotechnology Reviews
Verified
Journal Article
Open access
ASAnil K. Sharma
Anil K. Sharma
PSPravat K. Sahoo
Pravat K. Sahoo
DMDipak K. Majumdar
Dipak K. Majumdar
APAmulya K. Panda
Amulya K. Panda
The present investigation strives to formulate nanoparticles of poly-ε-caprolactone (PCL), containing celecoxib (CXB), a non-steroidal anti-inflammatory agent. The CXB-PCL nanoparticles were formulated by solvent displacement method and optimized based on formulation variables like drug-to-polymer ratio and surfactant concentration. The formulations were characterized for particle dimensions, surface morphology, physicochemical features, percentage drug incorporation efficiency, in vitro drug release, in vitro trans-corneal permeation, in vivo efficacy against arachidonic acid-induced ocular inflammation, and stability study. The prepared nanoparticles were nearly spherical having particle sizes ranging from 89.16±8.2 nm to 191.27±12.1 nm with maximum entrapment efficiency of 97.03±0.20%. The drug release was in sustained fashion (<75% drug released after 8 h) and obeyed zero-order release kinetics. The trans-corneal permeation was significantly higher than the aqueous suspension of CXB (p=0.05). Further, % hydration level was observed within permissible ranges suggesting ocular tolerability. The anti-inflammatory activity was found better as there was observed an improvement in parameters like lid closure score, PMN counts, and protein content against CXB aqueous suspension. The formulations were stable as evident from accelerated stability testing results. Thus, the CXB-PCL nanoparticles may prove a viable alternative to conventional dosage forms offering enhanced ocular bioavailability and compatibility with ocular milieu.

1 January 2016
Verified
Book Chapter
Closed access
RKRaj K. Keservani
Raj K. Keservani
RKRajesh K. Kesharwani
Rajesh K. Kesharwani
ASAnil K. Sharma
Anil K. Sharma

1 July 2024 in Biosciences Biotechnology Research Asia
Verified
Journal Article
Open access
SGSoniya Goyal
Soniya Goyal
AKAmit Kumar
Amit Kumar
PSPooja - Sharma
Pooja - Sharma
AGAnita Rani Gill
Anita Rani Gill
ASAnil Kumar Sharma
Anil Kumar Sharma
CSChahat Sharma
Chahat Sharma
Nitrogen is an essential nutrient utilized by living organisms to produce a number of organic molecules such as nucleic acid, amino acid and protein. A special class of microorganisms known as diazotrophs that are able to fix atmospheric nitrogen into biological form of nitrogen which is directly utilized by plants. Moreover, they stimulate plant growth by decreasing or preventing deleterious effects of pathogens through synthesis of antibiotics, competition for nutrients through production of siderophores. Along with terrestrial diazotrophs, various marine bacterial species are well known which involves in biological nitrogen fixation process. In an open oligotrophic ocean, pelagic and sympagic nitrogen fixation has been shown a significant source of biological nitrogen for survival of oceanic living organisms. A different range of diazotroph have been reported at low temperature ice sea environment. The community of nitrogen fixing bacteria under deep anoxic bottom water is gradually increase. It may be possible that due to genetic variation population of nitrogen fixing bacteria increases under sea water. In this review article, authors have focused on nature of diazotrophs in terrestrial as well as in aquatic conditions. Moreover, the bacterial habitat and their classification, latest approaches and future prospects is also included in the manuscript. Thus, the study would be helpful for understanding the mode of action, their behavior and survival rate in different environment and beneficial for improvement in agricultural sustainability.

1 April 2021 in Current Applied Polymer Science
Verified
Journal Article
Closed access
PDF file
VJVikas Jhawat
Vikas Jhawat
ASAnil Kumar Sharma
Anil Kumar Sharma
VGVandana Garg
Vandana Garg
MGMonika Gulia
Monika Gulia
RDRohit Dutt
Rohit Dutt
The nanoparticles as drug carriers have demonstrated enhanced targeting, sustained/controlled drug release as evident from numerous investigations which have shown promising outcomes facilitating the wellbeing of humans in a desired manner. The lipid based nanoparticulates are biodegradable and considered biocompatible by virtue of being composed of lipid moieties mimicking physiological lipids of biological systems which is their prime advantage over the other polymeric systems. A variety of such lipid carriers have been reported to be delivered from parenteral route. However, there are certain pitfalls which are associated with lipid nanoparticulates such as toxicity, poor scale up potential, immunological reactions and absence of straight forward regulatory guidelines which address the issues of lipoidal nanocarriers such as their classification, approval and compliance of governmental policies. Therefore attention must be given to address the technological and regulatory challenges associated with lipoidal nano-formulations for parenteral administration to smoothen the approval process throughout the world and bringing the same to the terminal users on time.